Chuck Royce's USNA Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 45,411 shares of USANA Health Sciences, Inc. (USNA) worth $793,330, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Chuck Royce has maintained a long-term strategic position in USNA, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2025, adding 8,247 shares. Largest reduction occurred in Q1 2026, reducing 7,144 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's USANA Health Sciences (USNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly USANA Health Sciences (USNA) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -7,144 | Reduce 13.59% | 45,411 | $17.47 |
| Q4 2025 | +8,247 | Add 18.61% | 52,555 | $19.63 |
| Q3 2025 | -5,671 | Reduce 11.35% | 44,308 | $27.55 |
| Q2 2025 | +5,144 | Add 11.47% | 49,979 | $30.53 |
| Q1 2025 | +5,921 | Add 15.22% | 44,835 | $26.97 |
| Q4 2024 | +5,771 | Add 17.41% | 38,914 | $35.89 |
| Q3 2024 | +6,031 | Add 22.24% | 33,143 | $37.92 |
| Q2 2024 | +1,096 | Add 4.21% | 27,112 | $45.24 |
| Q1 2024 | +710 | Add 2.81% | 26,016 | $48.50 |
| Q4 2023 | +3,695 | Add 17.10% | 25,306 | $53.60 |
| Q3 2023 | -1,501 | Reduce 6.49% | 21,611 | $58.61 |
| Q2 2023 | -395 | Reduce 1.68% | 23,112 | $63.04 |
| Q1 2023 | +2,547 | Add 12.15% | 23,507 | $62.90 |
| Q4 2022 | +7,138 | Add 51.64% | 20,960 | $53.20 |
| Q3 2022 | +7,317 | Add 112.48% | 13,822 | $56.07 |
| Q2 2022 | +6,505 | New Buy | 6,505 | $72.41 |
| Q3 2021 | -2,945 | Sold Out | 0 | $0.00 |
| Q2 2021 | -685 | Reduce 18.87% | 2,945 | $102.55 |
| Q1 2021 | -627 | Reduce 14.73% | 3,630 | $97.52 |
| Q4 2020 | +604 | Add 16.53% | 4,257 | $77.05 |
| Q3 2020 | +29 | Add 0.80% | 3,653 | $73.64 |
| Q2 2020 | +2 | Add 0.06% | 3,624 | $73.40 |
| Q1 2020 | -58 | Reduce 1.58% | 3,622 | $57.70 |
| Q4 2019 | +2,984 | Add 428.74% | 3,680 | $78.53 |
| Q3 2019 | +261 | Add 60.00% | 696 | $68.97 |
| Q2 2019 | +54 | Add 14.17% | 435 | $80.46 |
| Q1 2019 | +152 | Add 66.38% | 381 | $83.99 |
| Q4 2018 | -25 | Reduce 9.84% | 229 | $117.90 |
| Q3 2018 | +88 | Add 53.01% | 254 | $122.05 |
| Q2 2018 | +25 | Add 17.73% | 166 | $114.46 |
| Q1 2018 | -20 | Reduce 12.42% | 141 | $85.11 |
| Q4 2017 | -23 | Reduce 12.50% | 161 | $74.53 |
| Q3 2017 | +184 | New Buy | 184 | $59.78 |
| Q1 2015 | -1,600 | Sold Out | 0 | $0.00 |
| Q2 2013 | +1,600 | Add 0.00% | 1,600 | $36.25 |
Chuck Royce's USANA Health Sciences Investment FAQs
Chuck Royce first purchased USANA Health Sciences, Inc. (USNA) in Q2 2013, acquiring 1,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held USANA Health Sciences, Inc. (USNA) for 41 quarters since Q2 2013.
Chuck Royce's largest addition to USANA Health Sciences, Inc. (USNA) was in Q4 2025, adding 52,555 shares worth $1.03 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 45,411 shares of USANA Health Sciences, Inc. (USNA), valued at approximately $793,330.
As of the Q1 2026 filing, USANA Health Sciences, Inc. (USNA) represents approximately 0.01% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in USANA Health Sciences, Inc. (USNA) was 52,555 shares, as reported at the end of Q4 2025.